• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Sulfanilides

N-(4-AMINOPHENYL)-2,3-DIHYDRO-1,4-BENZODIOXINE-6-SULFONAMIDE: A Comprehensive Overview

N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide (CAS No. 792954-01-9) is a compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of benzodioxine sulfonamides, which are known for their diverse biological activities, including anti-inflammatory, anti-cancer, and neuroprotective effects. In this article, we will delve into the chemical structure, synthesis methods, biological activities, and recent research advancements of this compound.

The chemical structure of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide is characterized by a benzodioxine ring system fused with a sulfonamide group. The presence of the aminophenyl substituent on the benzodioxine ring imparts additional functional versatility to the molecule. The benzodioxine moiety is a six-membered ring with two oxygen atoms in the 1 and 4 positions, which provides a rigid and planar structure that can interact with various biological targets. The sulfonamide group, on the other hand, is known for its ability to form hydrogen bonds and participate in electrostatic interactions, making it a valuable functional group in drug design.

The synthesis of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide typically involves several steps. One common approach is to start with 2,3-dihydrobenzodioxine-6-sulfonyl chloride and react it with 4-aminophenylamine under appropriate conditions. The reaction can be carried out in a polar aprotic solvent such as dimethylformamide (DMF) or dimethyl sulfoxide (DMSO) in the presence of a base like triethylamine (TEA) or pyridine. This method yields the desired product in good yield and purity. Recent advancements in synthetic chemistry have also explored alternative routes to improve the efficiency and scalability of the synthesis process.

One of the key areas of interest in the study of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide is its biological activity. Research has shown that this compound exhibits potent anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These cytokines play a crucial role in various inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. The mechanism of action involves the modulation of nuclear factor-kappa B (NF-κB) signaling pathways, which are central to inflammation.

In addition to its anti-inflammatory effects, N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide has also been investigated for its anti-cancer properties. Studies have demonstrated that this compound can induce apoptosis in various cancer cell lines by disrupting mitochondrial function and activating caspase cascades. The selective cytotoxicity against cancer cells makes it a promising candidate for further development as an anticancer agent. Recent research has also explored its potential synergistic effects when combined with other chemotherapeutic drugs.

Another area of research focuses on the neuroprotective effects of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide. Preclinical studies have shown that this compound can protect neurons from oxidative stress-induced damage by scavenging free radicals and enhancing antioxidant defense mechanisms. This property makes it a potential therapeutic agent for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Ongoing clinical trials are evaluating its safety and efficacy in these conditions.

The pharmacokinetic properties of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide have also been studied to understand its behavior in vivo. Research has shown that this compound has good oral bioavailability and favorable pharmacokinetic parameters such as half-life and distribution volume. These properties are essential for ensuring that the drug reaches its target tissues at therapeutic concentrations without causing significant side effects.

Recent advancements in computational chemistry have further enhanced our understanding of N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide's interactions with biological targets. Molecular docking studies have identified key residues involved in binding to specific receptors and enzymes. This information is valuable for rational drug design and optimization efforts aimed at improving potency and selectivity.

In conclusion, N-(4-Aminophenyl)-2,3-dihydro-1,4-benzodioxine-6-sulfonamide (CAS No. 792954-01-9) is a promising compound with diverse biological activities that make it an attractive candidate for further research and development in medicinal chemistry. Its unique chemical structure and favorable pharmacological properties position it as a potential therapeutic agent for various diseases. Ongoing studies continue to explore its full potential and optimize its use in clinical settings.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)